AKT1 and T-cell acute lymphoblastic leukemia: Treatment resistance in T cell acute lymphoblastic leukemia (T-ALL) is associated with PTEN deletions which result in the activation of the PI3K-Akt pathway, and Notch1-mediated c-Myc overexpression [504, 505].